LATEST
Pfizer Establishes New Partnering Model for Early-Stage Academic Research
By
Pfizer has created a new, early-stage partnering model (Innovative Target Exploration Network [ITEN]) to enable relationships with select academic institutions and principal investigators to identify research projects and deliver therapeutic…
Frontida, Oncoceutics in Pact
By
Frontida BioPharm, a Philadelphia, Pennsylvania-headquartered contract development and manufacturing organization, has signed a pact with Oncoceutics, a Philadelphia-headquartered clinical-stage drug discovery and development company, to further develop and scale up…
FDA Grants Wacker OK to Manufacture Biologic API
By
Wacker Biotech, a Jena, Germany-headquartered contract manufacturer of biopharmaceutical proteins, has transferred the production process of Retavase (reteplase), a thrombolytic drug, to its Halle/Saale, Germany plant. Chiesi, a Parma, Italy-based…
Tesaro, Teneobio in Immuno-Oncology Pact
By
Tesaro, a San Antonio, Texas-headquartered oncology-focused biopharmaceutical company, has signed a research and license agreement with Teneobio, a Menlo Park, California-headquartered biotechnology company developing multi-specific antibody therapeutics. The companies have…
Takeda Announces Plans to Acquire Stem-Cell Company TiGenix for $620 Million
By
Takeda Pharmaceutical has entered into an offer agreement with TiGenix, a Leuven, Belgium-headquartered biopharmaceutical company developing stem-cell therapies, for a potential voluntary public takeover bid of approximately EUR 520 million…
